Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Clinical trial NCT00620633 · COMPLETED
Trial details
- NCT number
- NCT00620633
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-08
- Primary completion
- 2021-02-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.